NC
SURF

NinePointTwo Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

NinePointTwo Capital’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,206
Closed -$122K – 201
2021
Q3 		$122K Buy
+16,206
New +$104K 0.05% 68

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NinePointTwo Capital's SURF Position: Q4 2021 in Review

NinePointTwo Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2021, closing a stake of 16,206 shares — an estimated $122K sold.

NinePointTwo Capital first reported a position in SURF in Q3 2021 and held it in 1 quarter. The position peaked at $122K in Q3 2021. 106 funds tracked by Wall St. Rank hold SURF as of Q4 2021.

  • NinePointTwo Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • NinePointTwo Capital sold 16,206 Surface Oncology, Inc. Common Stock shares in Q4 2021, an estimated $122K.
  • NinePointTwo Capital first reported a position in Surface Oncology, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • NinePointTwo Capital's Surface Oncology, Inc. Common Stock position peaked at $122K in Q3 2021.
  • 106 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2021.

Based on NinePointTwo Capital's 13F filing for Q4 2021, filed 11 Feb 2022.